161 related articles for article (PubMed ID: 12684503)
1. Identification of the human receptor activity-modifying protein 1 domains responsible for agonist binding specificity.
Kuwasako K; Kitamura K; Nagoshi Y; Cao YN; Eto T
J Biol Chem; 2003 Jun; 278(25):22623-30. PubMed ID: 12684503
[TBL] [Abstract][Full Text] [Related]
2. The transmembrane domain of receptor-activity-modifying protein 1 is essential for the functional expression of a calcitonin gene-related peptide receptor.
Steiner S; Muff R; Gujer R; Fischer JA; Born W
Biochemistry; 2002 Sep; 41(38):11398-404. PubMed ID: 12234182
[TBL] [Abstract][Full Text] [Related]
3. Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptors.
Kuwasako K; Cao YN; Chu CP; Iwatsubo S; Eto T; Kitamura K
J Biol Chem; 2006 Mar; 281(11):7205-13. PubMed ID: 16410241
[TBL] [Abstract][Full Text] [Related]
4. The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors.
Kuwasako K; Kitamura K; Ito K; Uemura T; Yanagita Y; Kato J; Sakata T; Eto T
J Biol Chem; 2001 Dec; 276(52):49459-65. PubMed ID: 11591721
[TBL] [Abstract][Full Text] [Related]
5. Protein-protein interaction and not glycosylation determines the binding selectivity of heterodimers between the calcitonin receptor-like receptor and the receptor activity-modifying proteins.
Hilairet S; Foord SM; Marshall FH; Bouvier M
J Biol Chem; 2001 Aug; 276(31):29575-81. PubMed ID: 11387328
[TBL] [Abstract][Full Text] [Related]
6. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
[TBL] [Abstract][Full Text] [Related]
7. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.
Kamitani S; Sakata T
Biochim Biophys Acta; 2001 May; 1539(1-2):131-9. PubMed ID: 11389975
[TBL] [Abstract][Full Text] [Related]
9. Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus.
Nikitenko LL; Brown NS; Smith DM; MacKenzie IZ; Bicknell R; Rees MC
Mol Hum Reprod; 2001 Jul; 7(7):655-64. PubMed ID: 11420389
[TBL] [Abstract][Full Text] [Related]
10. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
[TBL] [Abstract][Full Text] [Related]
11. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
12. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
13. Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function.
Husmann K; Sexton PM; Fischer JA; Born W
Mol Cell Endocrinol; 2000 Apr; 162(1-2):35-43. PubMed ID: 10854696
[TBL] [Abstract][Full Text] [Related]
14. The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor.
Nagoshi Y; Kuwasako K; Ito K; Uemura T; Kato J; Kitamura K; Eto T
Eur J Pharmacol; 2002 Aug; 450(3):237-43. PubMed ID: 12208315
[TBL] [Abstract][Full Text] [Related]
15. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
[TBL] [Abstract][Full Text] [Related]
16. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
Moad HE; Pioszak AA
Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
[TBL] [Abstract][Full Text] [Related]
17. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells.
Aldecoa A; Gujer R; Fischer JA; Born W
FEBS Lett; 2000 Apr; 471(2-3):156-60. PubMed ID: 10767413
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of RAMP1 by alanine mutagenesis.
Simms J; Hay DL; Bailey RJ; Konycheva G; Bailey G; Wheatley M; Poyner DR
Biochemistry; 2009 Jan; 48(1):198-205. PubMed ID: 19072332
[TBL] [Abstract][Full Text] [Related]
19. The function of conserved cysteine residues in the extracellular domain of human receptor-activity-modifying protein.
Steiner S; Born W; Fischer JA; Muff R
FEBS Lett; 2003 Dec; 555(2):285-90. PubMed ID: 14644429
[TBL] [Abstract][Full Text] [Related]
20. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure.
Cueille C; Pidoux E; de Vernejoul MC; Ventura-Clapier R; Garel JM
Biochem Biophys Res Commun; 2002 Jun; 294(2):340-6. PubMed ID: 12051717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
